These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7898918)

  • 1. Spatial organization of ABR and CRK genes on human chromosome band 17p13.3.
    Morris C; Benjes S; Haataja L; Ledbetter DH; Heisterkamp N; Groffen J
    Oncogene; 1995 Mar; 10(5):1009-11. PubMed ID: 7898918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma.
    McDonald JD; Daneshvar L; Willert JR; Matsumura K; Waldman F; Cogen PH
    Genomics; 1994 Sep; 23(1):229-32. PubMed ID: 7829075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRK proto-oncogene maps to human chromosome band 17p13.
    Fioretos T; Heisterkamp N; Groffen J; Benjes S; Morris C
    Oncogene; 1993 Oct; 8(10):2853-5. PubMed ID: 8378094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of 14-3-3{varepsilon} and CRK: a clinical syndrome with macrocephaly, developmental delay, and generalized epilepsy.
    Tenney JR; Hopkin RJ; Schapiro MB
    J Child Neurol; 2011 Feb; 26(2):223-7. PubMed ID: 20833799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
    Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H
    Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and chromosomal localization of CRKL, a human crk-like gene.
    ten Hoeve J; Morris C; Heisterkamp N; Groffen J
    Oncogene; 1993 Sep; 8(9):2469-74. PubMed ID: 8361759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine mapping of an apparently targeted latent human herpesvirus type 6 integration site in chromosome band 17p13.3.
    Morris C; Luppi M; McDonald M; Barozzi P; Torelli G
    J Med Virol; 1999 May; 58(1):69-75. PubMed ID: 10223549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers.
    Konishi H; Takahashi T; Kozaki K; Yatabe Y; Mitsudomi T; Fujii Y; Sugiura T; Matsuda H; Takahashi T; Takahashi T
    Oncogene; 1998 Oct; 17(16):2095-100. PubMed ID: 9798680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion within the D17S34 locus in a primitive neuroectodermal tumor.
    Haataja L; Raffel C; Ledbetter DH; Tanigami A; Petersen D; Heisterkamp N; Groffen J
    Cancer Res; 1997 Jan; 57(1):32-4. PubMed ID: 8988035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
    Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
    Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
    Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
    Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal localization of phospholipase A2 activating protein, an Ets2 target gene, to 9p21.
    Beatty BG; Qi S; Pienkowska M; Herbrick JA; Scheidl T; Zhang ZM; Kola I; Scherer SW; Seth A
    Genomics; 1999 Dec; 62(3):529-32. PubMed ID: 10644453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further delineation of 17p13.3 microdeletion involving CRK. The effect of growth hormone treatment.
    Østergaard JR; Graakjær J; Brandt C; Birkebæk NH
    Eur J Med Genet; 2012 Jan; 55(1):22-6. PubMed ID: 22085993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.
    Fabris S; Mosca L; Todoerti K; Cutrona G; Lionetti M; Intini D; Matis S; Colombo M; Agnelli L; Gentile M; Spriano M; Callea V; Festini G; Molica S; Lambertenghi Deliliers G; Morabito F; Ferrarini M; Neri A
    Genes Chromosomes Cancer; 2008 Sep; 47(9):781-93. PubMed ID: 18521849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WNT and FGF gene clusters (review).
    Katoh M
    Int J Oncol; 2002 Dec; 21(6):1269-73. PubMed ID: 12429977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and transcriptional mapping of the 17p13.3 region that is frequently deleted in human cancer.
    Hoff C; Seranski P; Mollenhauer J; Korn B; Detzel T; Reinhardt R; Ramser J; Poustka A
    Genomics; 2000 Nov; 70(1):26-33. PubMed ID: 11087658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group.
    Lastowska M; Nacheva E; McGuckin A; Curtis A; Grace C; Pearson A; Bown N
    Genes Chromosomes Cancer; 1997 Mar; 18(3):162-9. PubMed ID: 9071568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-inducible SIPA1 is mapped to the conserved syntenic groups of chromosome 19 in mouse and chromosome 11q13.3 centromeric to BCL1 in human.
    Wada Y; Kubota H; Maeda M; Taniwaki M; Hattori M; Imamura S; Iwai K; Minato N
    Genomics; 1997 Jan; 39(1):66-73. PubMed ID: 9027487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T; Nomura N; Mori H; Wake N
    Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.